Click the JOIN button if you think you might be eligible for this study. Please complete the form below with your contact information. By completing this form, you are providing your permission (consent) for research professionals to contact you about active or future studies and health research news. Email Address * First Name * Last Name *
Click the JOIN button if you think you might be eligible for this study. Please complete the form below with your contact information. By completing this form, you are providing your permission (consent) for research professionals to contact you about active or future studies and health research news. Email Address * First Name * Last Name *
Click the JOIN button if you think you might be eligible for this study. Please complete the form below with your contact information. By completing this form, you are providing your permission (consent) for research professionals to contact you about active or future studies and health research news. Email Address * First Name * Last Name *
This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure.
Donating blood may do more than just help others—it could also enhance the health of your own blood cells. A recent study suggests that frequent blood donation may encourage the growth of beneficial blood cell mutations, potentially lowering the risk of blood-related diseases. Researchers at the Francis Crick Institute in London analyzed blood samples from
Living with chronic kidney disease and high blood pressure? You may qualify for a clinical trial testing baxdrostat with dapagliflozin to help protect kidney function and heart health. Receive expert care, close monitoring, and be part of shaping future treatments.
The purpose of this study is to investigate the effect of balcinrenone/dapagliflozin compared with dapagliflozin, on the risk of CV death, HF event with and without hospitalisation, in patients with chronic HF, impaired kidney function, and who have had a recent HF event.
Click the JOIN button if you think you might be eligible for this study. Please complete the form below with your contact information. By completing this form, you are providing your permission (consent) for research professionals to contact you about active or future studies and health research news. Email Address * First Name * Last Name *
A recent study conducted by researchers from Stanford Medicine, published in JAMA Network Open, reveals that adopting a vegan diet can lead to significant improvements in cardiovascular health within just eight weeks. The study, unique for its focus on identical twins, aimed to eliminate genetic and lifestyle variations that often complicate diet research. Involving 44
This clinical research study is being conducted to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get ziltivekimab or placebo. The study is expected to last for up to 4 years. Participants will have up to 20 clinic visits.
